The National Health Council (NHC) appreciates the opportunity to provide comments on the Food and Drug Administration’s (FDA’s) draft guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input. The […]
FDA regulations
Gottlieb Discusses Importance of Patient Engagement at NHC’s Dialogue on FDA Guidance
Today, FDA Commissioner, Scott Gottlieb, MD, spoke at our event, a dialogue on FDA’s first draft guidance on patient-focused drug development. Meeting participants engaged and interacted with people from various […]